Literature DB >> 23798485

Much of late life cognitive decline is not due to common neurodegenerative pathologies.

Patricia A Boyle1, Robert S Wilson, Lei Yu, Alasdair M Barr, William G Honer, Julie A Schneider, David A Bennett.   

Abstract

OBJECTIVE: The pathologic indices of Alzheimer disease, cerebrovascular disease, and Lewy body disease accumulate in the brains of older persons with and without dementia, but the extent to which they account for late life cognitive decline remains unknown. We tested the hypothesis that these pathologic indices account for the majority of late life cognitive decline.
METHODS: A total of 856 deceased participants from 2 longitudinal clinical-pathologic studies, Rush Memory and Aging Project and Religious Orders Study, completed a mean of 7.5 annual evaluations, including 17 cognitive tests. Neuropathologic examinations provided quantitative measures of global Alzheimer pathology, amyloid load, tangle density, macroscopic infarcts, microinfarcts, and neocortical Lewy bodies. Random coefficient models were used to examine the linear relation of pathologic indices with global cognitive decline. In subsequent analyses, random change point models were used to examine the relation of the pathologic indices with the onset of terminal decline and rates of preterminal and terminal decline (ie, nonlinear decline).
RESULTS: Cognition declined a mean of about 0.11 U per year (estimate = -0.109, standard error [SE] = 0.004, p < 0.001), with significant individual differences in rates of decline; the variance estimate for the individual slopes was 0.013 (SE = 0.112, p < 0.001). In separate analyses, global Alzheimer pathology, amyloid, tangles, macroscopic infarcts, and neocortical Lewy bodies were associated with faster rates of decline and explained 22%, 6%, 34%, 2%, and 8% of the variation in decline, respectively. When analyzed simultaneously, the pathologic indices accounted for a total of 41% of the variation in decline, and the majority remained unexplained. Furthermore, in random change point models examining the influence of the pathologic indices on the onset of terminal decline and the preterminal and terminal components of the cognitive trajectory, the common pathologic indices accounted for less than a third of the variation in the onset of terminal decline and rates of preterminal and terminal decline.
INTERPRETATION: The pathologic indices of the common causes of dementia are important determinants of cognitive decline in old age and account for a large proportion of the variation in late life cognitive decline. Surprisingly, however, much of the variation in cognitive decline remains unexplained, suggesting that other important determinants of cognitive decline remain to be identified. Identification of the mechanisms that contribute to the large unexplained proportion of cognitive decline is urgently needed to prevent late life cognitive decline.
Copyright © 2013 American Neurological Association.

Entities:  

Mesh:

Year:  2013        PMID: 23798485      PMCID: PMC3845973          DOI: 10.1002/ana.23964

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  34 in total

Review 1.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

2.  Aging gracefully: compensatory brain activity in high-performing older adults.

Authors:  Roberto Cabeza; Nicole D Anderson; Jill K Locantore; Anthony R McIntosh
Journal:  Neuroimage       Date:  2002-11       Impact factor: 6.556

3.  Neurodegenerative basis of age-related cognitive decline.

Authors:  R S Wilson; S E Leurgans; P A Boyle; J A Schneider; D A Bennett
Journal:  Neurology       Date:  2010-09-15       Impact factor: 9.910

4.  The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

Authors:  M S Green; J A Kaye; M J Ball
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

5.  Cognitive decline in old age: separating retest effects from the effects of growing older.

Authors:  Robert S Wilson; Yan Li; Julia L Bienias; David A Bennett
Journal:  Psychol Aging       Date:  2006-12

6.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

7.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

8.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

9.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  143 in total

1.  Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline.

Authors:  Patricia A Boyle; Jingyun Yang; Lei Yu; Sue E Leurgans; Ana W Capuano; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Authors:  Robert S Wilson; Patricia A Boyle; Lei Yu; Eisuke Segawa; Joel Sytsma; David A Bennett
Journal:  Psychol Aging       Date:  2015-02-09

3.  Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.

Authors:  Alfredo Ramos-Miguel; Clare L Beasley; Andrew J Dwork; J John Mann; Gorazd Rosoklija; Alasdair M Barr; William G Honer
Journal:  Biol Psychiatry       Date:  2014-12-19       Impact factor: 13.382

4.  Disturbed sleep in preclinical cognitive impairment: cause and effect?

Authors:  Bryce A Mander
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

Review 5.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

6.  Negative social interactions and risk of mild cognitive impairment in old age.

Authors:  Robert S Wilson; Patricia A Boyle; Bryan D James; Sue E Leurgans; Aron S Buchman; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

7.  Residual decline in cognition after adjustment for common neuropathologic conditions.

Authors:  Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

8.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

9.  Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.

Authors:  Lei Yu; Vladislav A Petyuk; Chris Gaiteri; Sara Mostafavi; Tracy Young-Pearse; Raj C Shah; Aron S Buchman; Julie A Schneider; Paul D Piehowski; Ryan L Sontag; Thomas L Fillmore; Tujin Shi; Richard D Smith; Philip L De Jager; David A Bennett
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

10.  Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults.

Authors:  Robert J Dawe; Lei Yu; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Patricia A Boyle
Journal:  Neurobiol Aging       Date:  2018-05-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.